Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB IBB AMZN TSLA ALXN ILMN WYNN AMGN GMCR SLXP COST GILD AAPL CELG WDC SNDK INTU
Nyse: ACT V MCK LNKD IVV AGN LMT GS PXD SPG FDX IBM MMM CMI TWC GD NOC APD BDX PH
New Highs: IBB V ILMN ALXN LMT ORLY WHR AMGN MMM GMCR GD NOC HUM COST BXP EW SLG SBAC GILD SRE

The Hot Industries

Biotechnology 4
Aerospace/Defense Products & Services 2
Medical Appliances & Equipment 1

The Hot Sectors

Healthcare 6
Industrial Goods 4
Financial 3

AMRN Stock Chart


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

MTNB: Initiating Coverage On Matinas BioPharma - A New Player In The Fish Oil Market

30 Oct 2014, 8:00 amMatinas is developing MAT9001, a proprietary prescription grade omega-3 fatty acid composition, comprised of a complex mixture of omega-3 fatty acids, predominantly eicosapentaenoic acid (“EPA”), and docosapentaenoic acid (“DPA”), a rare and potent omega-3 fatty acid. The product also contains several other omega-3 fatty acids, including relatively small amounts of docosahexaenoic acid (“DHA ...
favicon

Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results

22 Oct 2014, 4:47 pmMy question about Achillion and ACH-3422 question sparked a robust Twitter debate, which I've reproduced below with some additional comments and explanatory notes. Click to view a price quote on ACHN . Click to research the Drugs industry.
favicon

Biotech Stock Mailbag: Keryx, Puma, Gilead, Arrowhead and Hate Mail Galore!

10 Oct 2014, 5:02 pmBiotech columnist Adam Feuerstein answers readers' questions about health care. Click to view a price quote on PBYI . Click to research the Drugs industry.